Comprehensive Rehabilitation of Oral Cancer

  • David S. Thylur
  • Brenda Capobres Villegas
  • Uttam K. SinhaEmail author


The management of oral cancer necessarily involves not only therapy directed toward improving survival but also rehabilitation of the patient with the goals of improving quality of life and preserving the patient’s dignity. Surgical resection, radiation therapy, and chemotherapy create substantial morbidity and deformity. Treatment of this region therefore has tremendous consequences for irreplaceable functions: mastication, deglutition, verbal communication, respiration, and facial expression. Moreover, cancer creates extensive psychosocial and financial burden for the patient, their families, and the society in general. The focus on quality of life as it pertains to rehabilitation is critical to understanding the oral cancer patient. This chapter is dedicated to the discussion of oral cancer rehabilitation, with an emphasis on functional considerations in order to achieve maximum conservation of activity and quality of life.


  1. 1.
    Funk GF, Karnell LH, Christensen AJ. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012;138(2):123–33. doi: 10.1001/archoto.2011.234.PubMedCrossRefGoogle Scholar
  2. 2.
    Blyth KM, McCabe P, Heard R, Clark J, Madill C, Ballard KJ. Cancers of the tongue and floor of mouth: five-year file audit within the acute phase. Am J Speech Lang Pathol. 2014;23(4):668–78. doi: 10.1044/2014_AJSLP-14-0003.PubMedCrossRefGoogle Scholar
  3. 3.
    Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69(3):751–60. doi: 10.1016/j.ijrobp.2007.04.021.PubMedCrossRefGoogle Scholar
  4. 4.
    Clavel S, Fortin B, Després P, et al. Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach. Int J Radiat Oncol Biol Phys. 2011;79(3):763–9. doi: 10.1016/j.ijrobp.2009.12.032.PubMedCrossRefGoogle Scholar
  5. 5.
    Elting LS, Keefe DM, Sonis ST, et al. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer. 2008;113(10):2704–13. doi: 10.1002/cncr.23898.PubMedCrossRefGoogle Scholar
  6. 6.
    Wang X, Hu C, Eisbruch A. Organ-sparing radiation therapy for head and neck cancer. Nat Rev Clin Oncol. 2011;8(11):639–48. doi: 10.1038/nrclinonc.2011.106.PubMedCrossRefGoogle Scholar
  7. 7.
    Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2009;73(3):779–88. doi: 10.1016/j.ijrobp.2008.05.040.PubMedCrossRefGoogle Scholar
  8. 8.
    Pepper J-P, Baker SR. Local flaps: cheek and lip reconstruction. JAMA Facial Plast Surg. 2013;15(5):374. doi: 10.1001/jamafacial.2013.1608.PubMedCrossRefGoogle Scholar
  9. 9.
    Webster JP. Crescentic peri-alar cheek excision for upper lip flap advancement with a short history of upper lip repair. Plast Reconstr Surg (1946). 1955;16(6):434–64. doi: 10.1097/00006534-195512000-00003.CrossRefGoogle Scholar
  10. 10.
    Matin MB, Dillon J. Lip reconstruction. Oral Maxillofac Surg Clin N Am. 2014;26(3):335–57. doi: 10.1016/j.coms.2014.05.013.CrossRefGoogle Scholar
  11. 11.
    Neligan PC. Strategies in lip reconstruction. Clin Plast Surg. 2009;36(3):477–85. doi: 10.1016/j.cps.2009.02.013.PubMedCrossRefGoogle Scholar
  12. 12.
    Chang YM, Rodriguez ED, Chu YM, Tsai CY, Wei FC. Inferior alveolar nerve reconstruction with interpositional sural nerve graft: a sensible addition to one-stage mandibular reconstruction. J Plast Reconstr Aesthet Surg. 2012;65(6):757–62. doi: 10.1016/j.bjps.2011.12.028.PubMedCrossRefGoogle Scholar
  13. 13.
    Chen C-K, Tang Y. Myectomy and botulinum toxin for paralysis of the marginal mandibular branch of the facial nerve: a series of 76 cases. Plast Reconstr Surg. 2007;120(7):1859–64. doi: 10.1097/01.prs.0000287136.22709.77.PubMedCrossRefGoogle Scholar
  14. 14.
    Urken ML. The restoration or preservation of sensation in the oral cavity following ablative surgery. Arch Otolaryngol Head Neck Surg. 1995;121(6):607–12. doi: 10.1001/archotol.1995.01890060005001.PubMedCrossRefGoogle Scholar
  15. 15.
    May M, Sobol SM, Mester SJ. Hypoglossal-facial nerve interpositional-jump graft for facial reanimation without tongue atrophy. Otolaryngol Head Neck Surg. 1991;104(6):818–25.PubMedCrossRefGoogle Scholar
  16. 16.
    Harirchian S, Baredes S. Use of AlloDerm in primary reconstruction after resection of squamous cell carcinoma of the lip and oral commissure. Am J Otolaryngol – Head Neck Med Surg. 2013;34(5):611–3. doi: 10.1016/j.amjoto.2013.03.003.Google Scholar
  17. 17.
    Matsuo K. Anatomy and physiology of feeding and swallowing-normal and abnormal. Phys Med Rehabil Clin N Am 2009;19(4):691–707. doi: 10.1016/j.pmr.2008.06.001.Anatomy. (Johns Hopkins).
  18. 18.
    Murphy BA, Gilbert J. Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol. 2009;19(1):35–42. doi: 10.1016/j.semradonc.2008.09.007.PubMedCrossRefGoogle Scholar
  19. 19.
    Chang EI, Yu P, Skoracki RJ, Liu J, Hanasono MM. Comprehensive analysis of functional outcomes and survival after microvascular reconstruction of glossectomy defects. Ann Surg Oncol. 2015;22(9):3061–9. doi: 10.1245/s10434-015-4386-6.PubMedCrossRefGoogle Scholar
  20. 20.
    Lazarus CL, Husaini H, Anand SM, et al. Tongue strength as a predictor of functional outcomes and quality of life after tongue cancer surgery. Ann Otol Rhinol Laryngol. 2013;122(6):386–97. Scholar
  21. 21.
    Lee DY, Ryu Y-J, Hah JH, Kwon T-K, Sung M-W, Kim KH. Long-term subjective tongue function after partial glossectomy. J Oral Rehabil. 2014;41(10):754–8. doi: 10.1111/joor.12193.PubMedCrossRefGoogle Scholar
  22. 22.
    Blyth KM, McCabe P, Madill C, Ballard KJ. Speech and swallow rehabilitation following partial glossectomy: a systematic review. Int J Speech Lang Pathol. 2015;17(4):401–10. doi: 10.3109/17549507.2014.979880.PubMedCrossRefGoogle Scholar
  23. 23.
    Brown L, Rieger JM, Harris J, Seikaly H. A longitudinal study of functional outcomes after surgical resection and microvascular reconstruction for oral cancer: tongue mobility and swallowing function. J Oral Maxillofac Surg. 2010;68(11):2690–700. doi: 10.1016/j.joms.2010.05.004.PubMedCrossRefGoogle Scholar
  24. 24.
    Dziegielewski PT, Ho ML, Rieger J, et al. Total glossectomy with laryngeal preservation and free flap reconstruction: objective functional outcomes and systematic review of the literature. Laryngoscope. 2013;123(1):140–5. doi: 10.1002/lary.23505.PubMedCrossRefGoogle Scholar
  25. 25.
    Lin DT, Yarlagadda BB, Sethi RKV, et al. Long-term functional outcomes of total glossectomy with or without total laryngectomy. JAMA Otolaryngol Neck Surg. 2015;0910:1–7. doi: 10.1001/jamaoto.2015.1463.Google Scholar
  26. 26.
    Kapur KK, Garrett NR, Fischer E. Effects of anaesthesia of human oral structures on masticatory performance and food particle size distribution. Arch Oral Biol. 1990;35(5):397–403. doi: 10.1016/0003-9969(90)90187-F.PubMedCrossRefGoogle Scholar
  27. 27.
    Shindo ML, Sinha UK, Rice DH. Sensory recovery in noninnervated free flaps for head and neck reconstruction. Laryngoscope. 1995;105(12 Pt 1):1290–3. doi: 10.1016/S0278-2391(96)90366-3.PubMedCrossRefGoogle Scholar
  28. 28.
    Ozkan O, Ozkan O, Derin AT, et al. True functional reconstruction of total or subtotal glossectomy defects using a chimeric anterolateral thigh flap with both sensorial and motor innervation. Ann Plast Surg. 2015;74(5):557–64. doi: 10.1097/SAP.0b013e3182a6add7.PubMedCrossRefGoogle Scholar
  29. 29.
    Baas M, Duraku LS, Corten EML, Mureau MAM. A systematic review on the sensory reinnervation of free flaps for tongue reconstruction: Does improved sensibility imply functional benefits? J Plast Reconstr Aesthet Surg. 2015;68(8):1025–35. doi: 10.1016/j.bjps.2015.04.020.PubMedCrossRefGoogle Scholar
  30. 30.
    Cordeiro PG, Disa JJ, Hidalgo DA, Hu QY. Reconstruction of the mandible with osseous free flaps: a 10-year experience with 150 consecutive patients. Plast Reconstr Surg. 1999;104(5):1314–20. doi: 10.1097/00006534-199910000-00011.PubMedCrossRefGoogle Scholar
  31. 31.
    Hidalgo DA, Pusic AL. Free-flap mandibular reconstruction: a 10-year follow-up study. Plast Reconstr Surg. 2002;110(2):438–49. discussion 450–451 doi: 10.1097/00006534-200208000-00010.PubMedCrossRefGoogle Scholar
  32. 32.
    Urken ML, Buchbinder D, Costantino PD, et al. Oromandibular reconstruction using microvascular composite flaps: report of 210 cases. Arch Otolaryngol Head Neck Surg. 1998;124(1):46–55.PubMedCrossRefGoogle Scholar
  33. 33.
    Kuriakose MA, Shnayder Y, DeLacure MD. Reconstruction of segmental mandibular defects by distraction osteogenesis for mandibular reconstruction. Head Neck. 2003;25(10):816–24. doi: 10.1002/hed.10294.PubMedCrossRefGoogle Scholar
  34. 34.
    Irish JC, Gullane PJ, Gilbert RW, Brown DH, Birt BD, Boyd JB. Primary mandibular reconstruction with the titanium hollow screw reconstruction plate: evaluation of 51 cases. Plast Reconstr Surg. 1995;96(1):93–9. doi: 10.1097/00006534-199507000-00014.PubMedCrossRefGoogle Scholar
  35. 35.
    Knott PD, Suh JD, Nabili V, et al. Evaluation of hardware-related complications in vascularized bone grafts with locking mandibular reconstruction plate fixation. Arch Otolaryngol Head Neck Surg. 2007;133(12):1302–6. doi: 10.1001/archotol.133.12.1302.PubMedCrossRefGoogle Scholar
  36. 36.
    Blackwell KE, Buchbinder D, Urken ML. Lateral mandibular reconstruction using soft-tissue free flaps and plates. Arch Otolaryngol Head Neck Surg. 1996;122(6):672–8. doi: 10.1001/archotol.1996.01890180078018.PubMedCrossRefGoogle Scholar
  37. 37.
    Ben-David MA, Diamante M, Radawski JD, et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007;68(2):396–402. doi: 10.1016/j.ijrobp.2006.11.059.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Odell K, Sinha UK. Management of osteoradionecrosis of the mandible. Oral Maxillofac Surg Clin N Am. 2011;23:455–64. doi: 10.1016/j.coms.2011.04.011 2011.CrossRefGoogle Scholar
  39. 39.
    Ch’ng S, Skoracki RJ, Selber JC, et al. Osseointegrated implant based dental rehabilitation in head and neck reconstruction patients. Head Neck. 2014;55(7):691–6. doi: 10.1002/hed.23993.Google Scholar
  40. 40.
    Barber AJ, Butterworth CJ, Rogers SN. Systematic review of primary osseointegrated dental implants in head and neck oncology. Br J Oral Maxillofac Surg. 2011;49(1):29–36. doi: 10.1016/j.bjoms.2009.12.007.PubMedCrossRefGoogle Scholar
  41. 41.
    Walsh LJ. Clinical assessment and management of the oral environment in the oncology patient. Aust Dent J. 2010;55(Suppl 1):66–77. doi: 10.1111/j.1834-7819.2010.01201.x.PubMedCrossRefGoogle Scholar
  42. 42.
    Vissink A, Jansma J, Spijkervet FKL, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199–212. doi: 10.1177/154411130301400305.PubMedCrossRefGoogle Scholar
  43. 43.
    Barata, LF, Carvalho, GB, Carrara-de Angelis, E, Faria, JCM, Kowalski, LP. Swallowing, speech and quality of life in patients undergoing resection of soft palate. Eur Arch Otorhinolaryngol. 2012; 270(1):305–312. doi: 10.1007/s00405-012-2006-7.
  44. 44.
    Sinha UK, Young P, Hurvitz K. Functional outcome of palatal reconstruction using folded radial forearm free flap. Ear Nose Throat J. 2004;83:45–48. PMID: 14986758.Google Scholar
  45. 45.
    Irish J, Sandhu N, Simpson C, et al. Quality of life in patients with maxillectomy prostheses. Head Neck. 2009;31(6):813–21. doi: 10.1002/hed.21042.PubMedCrossRefGoogle Scholar
  46. 46.
    Bohle G, Rieger J, Huryn J, Verbel D, Hwang F, Zlotolow I. Efficacy of speech aid prostheses for acquired defects of the soft palate and velopharyngeal inadequacy – clinical assessments and cephalometric analysis: a memorial sloan-kettering study. Head Neck. 2005;27(3):195–207. doi: 10.1002/hed.10360.PubMedCrossRefGoogle Scholar
  47. 47.
    Jensen SB, Jarvis V, Zadik Y, et al. Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3223–32. doi: 10.1007/s00520-013-1884-6.PubMedCrossRefGoogle Scholar
  48. 48.
    Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–61. doi: 10.1002/cncr.28592.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Bossi P, Locati LD, Licitra L. Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profile. J Clin Oncol. 2012;30(5):564–5. doi: 10.1200/JCO.2011.39.1136.PubMedCrossRefGoogle Scholar
  50. 50.
    Le Q-T, Kim HE, Schneider CJ, et al. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol. 2011;29(20):2808–14. doi: 10.1200/JCO.2010.32.4095.PubMedCrossRefGoogle Scholar
  51. 51.
    Henke M, Alfonsi M, Foa P, et al. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol. 2011;29(20):2815–20. doi: 10.1200/JCO.2010.32.4103.PubMedCrossRefGoogle Scholar
  52. 52.
    Gu J, Zhu S, Li X, Wu H, Li Y, Hua F. Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials. PLoS One. 2014;9(5) doi: 10.1371/journal.pone.0095968.
  53. 53.
    McConnel FM, Logemann JA, Rademaker AW, et al. Surgical variables affecting postoperative swallowing efficiency in oral cancer patients: a pilot study. Laryngoscope. 1994;104(1 Pt 1):87–90. doi: 10.1288/00005537-199401000-00015.PubMedGoogle Scholar
  54. 54.
    Weber RS, Ohlms L, Bowman J, Jacob R, Goepfert H. Functional results after total or near total glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg. 1991;117(5):512–5. doi: 10.1001/archotol.1991.01870170058013.PubMedCrossRefGoogle Scholar
  55. 55.
    Pauloski BR, Rademaker AW, Logemann JA, Colangelo LA. Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients. Otolaryngol Head Neck Surg. 1998;118(5):616–24. doi: 10.1016/S0194-5998(98)70230-X.PubMedGoogle Scholar
  56. 56.
    Sinha UK, Villegas B, Kuo C, et al. J Nucl Med Radiat Ther. 2014;5:4.–9619.1000197 Google Scholar
  57. 57.
    Furia CL, Carrara-de Angelis E, Martins NM, Barros AP, Carneiro B, Kowalski LP. Video fluoroscopic evaluation after glossectomy. Arch Otolaryngol Head Neck Surg. 2000;126(3):378–83.PubMedCrossRefGoogle Scholar
  58. 58.
    Leder SB, Sasaki CT, Burrell MI. Fiberoptic endoscopic evaluation of dysphagia to identify silent aspiration. Dysphagia. 1998;13(1):19–21. doi: 10.1007/PL00009544.PubMedCrossRefGoogle Scholar
  59. 59.
    Balou M, McCullough GH, Aduli F, et al. Manometric measures of head rotation and chin tuck in healthy participants. Dysphagia. 2014;29(1):25–32. doi: 10.1007/s00455-013-9472-y.PubMedCrossRefGoogle Scholar
  60. 60.
    Leigh J-H, Oh B-M, Seo HG, et al. Influence of the chin-down and chin-tuck maneuver on the swallowing kinematics of healthy adults. Dysphagia. 2014;30(1):89–98. doi: 10.1007/s00455-014-9580-3.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    McCabe D, Ashford J, Wheeler-Hegland K, et al. Evidence-based systematic review: oropharyngeal dysphagia behavioral treatments. Part IV – impact of dysphagia treatment on individuals’ postcancer treatments. J Rehabil Res Dev. 2009;46(2):205–14. doi: 10.1682/JRRD.2008.08.0092.PubMedCrossRefGoogle Scholar
  62. 62.
    Solazzo A, Monaco L, Del Vecchio L, et al. Investigation of compensatory postures with videofluoromanometry in dysphagia patients. World J Gastroenterol. 2012;18(23):2973–8. doi: 10.3748/wjg.v18.i23.2973.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Marunick M, Tselios N. The efficacy of palatal augmentation prostheses for speech and swallowing in patients undergoing glossectomy: a review of the literature. J Prosthet Dent. 2004;91(1):67–74. doi: 10.1016/j.prosdent.2003.10.012.PubMedCrossRefGoogle Scholar
  64. 64.
    Cousins N, MacAulay F, Lang H, MacGillivray S, Wells M. A systematic review of interventions for eating and drinking problems following treatment for head and neck cancer suggests a need to look beyond swallowing and trismus. Oral Oncol. 2013;49(5):387–400. doi: 10.1016/j.oraloncology.2012.12.002.PubMedCrossRefGoogle Scholar
  65. 65.
    Fleming SM, Weaver AW. Feeding device for glossectomy patients. Arch Phys Med Rehabil. 1983;64(4):183–5.PubMedGoogle Scholar
  66. 66.
    Sood AJ, Fox NF, O’Connell BP, et al. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis. Oral Oncol. 2014;50(2):77–83. doi: 10.1016/j.oraloncology.2013.10.010.PubMedCrossRefGoogle Scholar
  67. 67.
    Rieke JW, Hafermann MD, Johnson JT, et al. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. 1995. doi: 10.1016/0360-3016(94)00361-N.
  68. 68.
    Bensadoun R-J, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FKL, Brennan MT. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer. 2010;18(8):1033–8. doi: 10.1007/s00520-010-0847-4.PubMedCrossRefGoogle Scholar
  69. 69.
    Scherpenhuizen A, van Waes AM, Janssen LM, Van Cann EM, Stegeman I. The effect of exercise therapy in head and neck cancer patients in the treatment of radiotherapy-induced trismus: a systematic review. Oral Oncol. 2015;51(8):745–50. doi: 10.1016/j.oraloncology.2015.05.001.PubMedCrossRefGoogle Scholar
  70. 70.
    Pauli N, Fagerberg-Mohlin B, Andréll P, Finizia C. Exercise intervention for the treatment of trismus in head and neck cancer. Acta Oncol (Madr). 2014;53(4):502–9. doi: 10.3109/0284186X.2013.837583.CrossRefGoogle Scholar
  71. 71.
    Lee L-Y, Chen S-C, Chen W-C, Huang B-S, Lin C-Y. Postradiation trismus and its impact on quality of life in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(2):187–95. doi: 10.1016/j.oooo.2014.10.003.PubMedCrossRefGoogle Scholar
  72. 72.
    Irune E, Dwivedi R, Nutting C, Harrington K. Treatment-related dysgeusia in head and neck cancer patients. Cancer Treat Rev. 2014;40:1106–17.PubMedCrossRefGoogle Scholar
  73. 73.
    Francis DO, Hall E, Dang JH, Vlacich GR, Netterville JL, Vaezi MF. Outcomes of serial dilation for high-grade radiation-related esophageal strictures in head and neck cancer patients. Laryngoscope. 2015;125(4):856–62. doi: 10.1002/lary.24987.PubMedCrossRefGoogle Scholar
  74. 74.
    Chapuy CI, Annino DJ, Tishler RB, Haddad RI, Snavely A, Goguen LA. Success of endoscopic pharyngoesophageal dilation after head and neck cancer treatment. Laryngoscope. 2013;123(12):3066–73. doi: 10.1002/lary.24268.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Agarwalla A, Small AJ, Mendelson AH, Scott FI, Kochman ML. Risk of recurrent or refractory strictures and outcome of endoscopic dilation for radiation-induced esophageal strictures. Surg Endosc. 2015;29(7):1903–12. doi: 10.1007/s00464-014-3883-1.PubMedCrossRefGoogle Scholar
  76. 76.
    Van Den Berg MGA, Rütten H, Rasmussen-Conrad EL, et al. Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: a cross-sectional study. Head Neck. 2014;36(1):60–5. doi: 10.1002/hed.23265.PubMedCrossRefGoogle Scholar
  77. 77.
    Markkanen-Leppänen M, Isotalo E, Mäkitie AA, et al. Changes in articulatory proficiency following microvascular reconstruction in oral or oropharyngeal cancer. Oral Oncol. 2006;42(6):646–52. doi: 10.1016/j.oraloncology.2005.11.004.PubMedCrossRefGoogle Scholar
  78. 78.
    Furia CL, Kowalski LP, Latorre MR, et al. Speech intelligibility after glossectomy and speech rehabilitation. Arch Otolaryngol Head Neck Surg. 2001;127(7):877–83.PubMedGoogle Scholar
  79. 79.
    Ayliffe BW, Bressmann T, Al Mardini M, Jokstad A. Evaluation of a modular palatal lift prosthesis with a silicone velar lamina for hypernasal patients. J Prosthet Dent. 2014;112(3):663–71. doi: 10.1016/j.prosdent.2013.12.014.PubMedCrossRefGoogle Scholar
  80. 80.
    Haisfield-Wolfe ME, McGuire DB, Soeken K, Geiger-Brown J, De Forge BR. Prevalence and correlates of depression among patients with head and neck cancer: a systematic review of implications for research. Oncol Nurs Forum. 2009;36(3):E104–25. doi: 10.1188/09.ONF.E107-E125.CrossRefGoogle Scholar
  81. 81.
    Katz MR, Irish JC, Devins GM, Rodin GM, Gullane PJ. Psychosocial adjustment in head and neck cancer: the impact of disfigurement, gender and social support. Head Neck. 2003;25(2):103–12. doi: 10.1002/hed.10174.PubMedCrossRefGoogle Scholar
  82. 82.
    Lazure KE, Lydiatt WM, Denman D, Burke WJ. Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial. Head Neck. 2009;31(7):888–92. doi: 10.1002/hed.21046.PubMedCrossRefGoogle Scholar
  83. 83.
    Chen AM, Daly ME, Vazquez E, et al. Depression among long-term survivors of head and neck cancer treated with radiation therapy. JAMA Otolaryngol Neck Surg. 2013;139(9):885. doi: 10.1001/jamaoto.2013.4072.CrossRefGoogle Scholar
  84. 84.
    Semple C, Parahoo K, Norman A, McCaughan E, Humphris G, Mills M. Psychosocial interventions for patients with head and neck cancer. In: Semple C, editor. Cochrane database of systematic reviews. Wiley: Chichester; 2013. doi: 10.1002/14651858.CD009441.pub2.Google Scholar
  85. 85.
    Lydiatt WM. Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial. JAMA Otolaryngol Neck Surg. 2013;1225(7):1. doi: 10.1001/jamaoto.2013.3371.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • David S. Thylur
    • 1
  • Brenda Capobres Villegas
    • 1
  • Uttam K. Sinha
    • 1
    Email author
  1. 1.Department of Otolaryngology-Head and Neck SurgeryKeck school of Medicine at University of Southern CaliforniaLos AngelesUSA

Personalised recommendations